InnerScope Hearing Technologies (OTC: INND) Launches New Line of OTC Hearing Aids for its iHEAR Brand
InnerScope Hearing Technologies Inc. (OTC: INND) has launched a new line of affordable Over-the-Counter (OTC) hearing aids under the iHEAR brand, coinciding with the FDA's new regulations that allow OTC hearing aids to be sold without prescriptions. The new products, which range from $499.99 to $999.99, are designed for various lifestyles and include app-controlled models. InnerScope's well-established wholesale distribution network positions it advantageously in this emerging market. The company has almost 500,000 customers and continues to innovate in the direct-to-consumer hearing aid space.
- Launch of OTC hearing aids aligns with FDA regulations, enhancing market access.
- Established distribution network to major retailers and pharmacy chains.
- Approachable pricing ranging from $499.99 to $999.99 attracts a broader consumer base.
- Strong historical customer base of nearly 500,000 users.
- None.
iHEAR Offers a New Line of Affordable Over-the-Counter Hearing Aids to be Sold in Major Retailers and Pharmacy Chains
ROSEVILLE, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Over-the-Counter (OTC) Hearing space is pleased to announce the launch of its new line of affordable Over-the-Counter ("OTC") rechargeable hearing aids for its iHEAR brand which includes app-controlled models with full wireless audio streaming of music and hands-free phone calling ("iHEAR OTC Hearing Aids"). The launch of iHEAR OTC Hearing Aids coincides with the Food and Drug Administration ("FDA") finalizing the rule that started on October 17, 2022, which allows OTC hearing aids to be sold online and in major retail stores and pharmacy chains without a prescription or a need to see a medical or hearing professional from the Over-the-Counter Hearing Aid Act of 2017.
InnerScope, along with its wholly-owned subsidiary HearingAssist has been a leader in the direct-to-consumer hearing space since 2008, with nearly 500,000 customers. As a result, InnerScope is confident that it is in a prime position for this new emerging OTC hearing aid market, beginning with the launch of iHEAR OTC Hearing Aids and its well-established wholesale distribution network of major retailers and pharmacy chains.
InnerScope initially launched iHEAR OTC Hearing Aids with two model types and four levels of technology. The model types and levels of technology are for the individual to choose based on their lifestyle and current or desired listening environments. Prices range from
InnerScope has developed a quick and easy online guide for consumers to select the proper iHEAR OTC Hearing Aids and technology level. To find out which iHEAR OTC Hearing Aid is right for you, please visit: https://innd.outgrow.us/innd-97
"We designed these models and technology features in iHEAR's new OTC Hearing Aids for all different or desired lifestyles and individual hearing needs,” said Matthew Moore, President and CEO of InnerScope Hearing Technologies. "For example, the Premium Technology is for someone often in challenging listening environments, i.e., parties, large gatherings, and sporting events. The Advance Technology is for more moderate listening environments, i.e., restaurants, attending meetings, or religious services. The Essential Technology is for low-noise environments, i.e., family conversations around the dinner table. Our team of R&D engineers and our technology partners worldwide are continuing to develop new next-generation OTC hearing aids with voice-activated AI smart technology for the 48+ million Americans who are reported to have untreated hearing loss but could never afford the high cost of traditional prescription hearing aids."
iHEAR OTC Hearing Aid Rechargeable Models are:
- matriX – Premium Technology (
$999.99 / pair) – Everyday Wear – Receiver in Canal (RIC) Features:
- App-Controlled / Device Controlled
- Full Audio Steaming for Music and Hands-Free Phone Calls
- Able to Customize Environment Settings Using myiHEAR App
- 11-Volume Levels with 4-Environmental Programs
- Premium Directional / Bidirectional Microphone Technology
- Premium Digital Feedback Suppression (DFS)
- Premium Background Noise Reduction
- linX – Premium Technology (
$699.99 / pair) Occasional Wear – Modern Earbud Design Features:
- App-Controlled / Device Controlled
- Full Audio Steaming for Music and Hands-Free Phone Calls
- Able to Customize \Environment Settings Using myiHEAR App
- 11-Volume Levels with 4-Environment Programs
- Premium Directional / Bidirectional Microphone Technology
- Premium Digital Feedback Suppression (DFS)
- Premium Background Noise Reduction
- aXis – Advanced Technology (
$799.99 / pair) – Everyday Wear – Receiver in Canal (RIC) Features:
- App-Controlled / Device Controlled
- Able to Customize \ Environment Settings Using myiHEAR App
- 11-Volume Levels with 4-Environment Programs
- Advanced Directional Microphone Technology
- Advanced Digital Feedback Suppression (DFS)
- Advanced Background Noise Reduction
- Xplore – Essential Technology (
$499.99 / pair) – Everyday Wear – Receiver in Canal (RIC) Features:
- Easy and Simple to Use – No App Required
- Device Controlled
- 11-Volume Levels with 4-Environment Programs
- Essential Directional Microphone Technology
- Essential Directional Microphone Technology
- Essential Digital Feedback Suppression (DFS)
- Essential Background Noise Reduction
Consumers can purchase and find more information about iHEAR OTC Hearing Aids at: https://iHEARdirect.com/
About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):
InnerScope Hearing Technologies Inc. is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products ("Hearing Products") dedicated to addressing the global demand for affordable hearing solutions. InnerScope's Hearing Products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions.
InnerScope's recent acquisition of iHEAR Medical Inc., a Direct-to-Consumer ("DTC") cloud-based hearing solution provider, gives the Company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced Hearing Products through Walmart and many other major retailers and pharmacy chains.
InnerScope's full line of Hearing Products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health™ at-Home, FSAStore.com, HSAStore.com, and WellDeservedHealth.com. More in-store and online Hearing Products will soon launch with more major retailers and pharmacy chains.
For information related to InnerScope Hearing Technologies' latest hearing aids and related hearing products, please visit:
http://iHEARdirect.com
For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page: https://twitter.com/inndstock
InnerScope Hyperlinks:
iHEAR
HearingAssist
hearing assist - Walmart.com
Acquisition of iHEAR Medical Inc.
Acquisition of HearingAssist
Safe Harbor
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended intended to be covered by the "safe harbor" created by those sections. Any statements that are not historical facts contained in this press release are also "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission ("S.E.C."). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act, and Securities Exchange Act.
Contact:
InnerScope Hearing Technologies, Inc.
Investor Relations
ir@innd.com
833-788-0506
www.innd.com
Investor Relations Agency Contact:
Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager
One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: lisa@skylineccg.com
Attachment
FAQ
What is the significance of InnerScope's OTC hearing aids launch for INND?
When did the FDA finalize the rule allowing OTC hearing aids?
What price range do the new iHEAR OTC hearing aids fall into?
How many customers does InnerScope have?
